Evidence map›Paper›PMID 40821871›Full record

ArticleACS polymers Au2025

Stimuli-Responsive Oligolysine-PEG Coatings for Reductive-Triggered Decomplexation.

Hugo J Rodríguez-Franco, Artem Kononenko, Maartje M C Bastings

Abstract read
In one paragraph

Article in ACS polymers Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hugo J Rodríguez-FrancoProgrammable Biomaterials Laboratory, Institute of Materials, Interfaculty Bioengineering Institute, School of Engineering, Ecole Polytechnique Fédérale Lausanne, Lausanne 1015, Switzerland.ORCID https://orcid.org/0009-0008-7819-1624
Artem KononenkoProgrammable Biomaterials Laboratory, Institute of Materials, Interfaculty Bioengineering Institute, School of Engineering, Ecole Polytechnique Fédérale Lausanne, Lausanne 1015, Switzerland.ORCID https://orcid.org/0000-0001-8966-0512
Maartje M C BastingsProgrammable Biomaterials Laboratory, Institute of Materials, Interfaculty Bioengineering Institute, School of Engineering, Ecole Polytechnique Fédérale Lausanne, Lausanne 1015, Switzerland.ORCID https://orcid.org/0000-0002-7603-4018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA origami nanoparticles (DONs) hold great potential for interacting with biological systems, yet their applicability is limited by nuclease activity and challenging ionic conditions in biological environments. Among various stabilization strategies, oligolysine-PEG coatings have emerged as a preferred option due to their straightforward implementation and protective capacity. However, their static nature restricts compatibility with dynamic DON systems and may hinder the functional availability of preincorporated bioactive cues. Here, we introduce a strategy to confer responsiveness to these coatings by incorporating labile disulfide bridges at defined positions within the oligolysine segments. Upon exposure to the characteristic reductive conditions of the cellular cytoplasm, these linkers undergo cleavage, weakening the multivalent electrostatic interactions between the coatings and DONs. Through the synthesis and characterization of distinct oligolysine-PEG variants with varying degrees of peptide segmentation, we confirm their ability to protect DONs under physiological conditions while enabling efficient decomplexation in reductive environments, observing differences in DON functional recovery depending on the number and positioning of the linkers. This work provides a foundation for developing responsive oligolysine-PEG coatings, broadening the functional scope and biomedical applicability of stabilized DONs.

Indexed as

biointerfacesDNA origami nanoparticlesreductive deprotectionstabilizing coatingsstimuli-responsive polymers

Identifiers

PMID40821871
PMCPMC12355613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.